Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.11 | 1.93 |
NAV | ₹29.72 | ₹420.93 |
Fund Started | 04 Dec 2015 | 04 Jun 1999 |
Fund Size | ₹1310.50 Cr | ₹3989.42 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.11
1.93
NAV
₹29.72
₹420.93
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1310.50 Cr
₹3989.42 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year | -0.76% | 0.20% |
3 Year | 21.33% | 23.54% |
5 Year | 14.24% | 15.54% |
1 Year
-0.76%
0.20%
3 Year
21.33%
23.54%
5 Year
14.24%
15.54%
Equity | 98.68% | 96.59% |
Cash | 1.32% | 3.34% |
Equity
98.68%
96.59%
Cash
1.32%
3.34%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 7.88% |
Max Healthcare Institute Ltd. | 5.87% |
Abbott India Ltd. | 5.48% |
Divi's Laboratories Ltd. | 5.01% |
Healthcare Global Enterprises Ltd. | 4.84% |
Apollo Hospitals Enterprise Ltd. | 4.76% |
Cipla Ltd. | 4.14% |
Rainbow Children's Medicare Ltd. | 3.77% |
Ipca Laboratories Ltd. | 3.72% |
JB Chemicals & Pharmaceuticals Ltd. | 3.52% |
Sun Pharmaceutical Industries Ltd. | 11.64% |
Divi's Laboratories Ltd. | 7.05% |
Max Healthcare Institute Ltd. | 5.24% |
Lupin Ltd. | 4.44% |
Laurus Labs Ltd. | 3.89% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Acutaas Chemicals Ltd. | 3.85% |
Cipla Ltd. | 3.79% |
Lonza Group Ag | 3.63% |
Biocon Ltd. | 3.16% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 04 Dec 2015 | 04 Jun 1999 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999